BPTSY
Price
$3.04
Change
-$0.61 (-16.71%)
Updated
Dec 17 closing price
VACBF
Price
$0.24
Change
-$0.07 (-22.58%)
Updated
Nov 26 closing price
Ad is loading...

BPTSY vs VACBF

Header iconBPTSY vs VACBF Comparison
Open Charts BPTSY vs VACBFBanner chart's image
Biophytis SA
Price$3.04
Change-$0.61 (-16.71%)
Volume$1.79K
CapitalizationN/A
NYKODE THERAPEUTICS AS
Price$0.24
Change-$0.07 (-22.58%)
Volume$10.92K
CapitalizationN/A
BPTSY vs VACBF Comparison Chart
Loading...
BPTSY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VACBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BPTSY vs. VACBF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPTSY is a Hold and VACBF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (BPTSY: $3.04 vs. VACBF: $0.24)
Brand notoriety: BPTSY and VACBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPTSY: 434% vs. VACBF: 247%
Market capitalization -- BPTSY: $2.47M vs. VACBF: $97.91M
BPTSY [@Biotechnology] is valued at $2.47M. VACBF’s [@Biotechnology] market capitalization is $97.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPTSY’s FA Score shows that 1 FA rating(s) are green whileVACBF’s FA Score has 1 green FA rating(s).

  • BPTSY’s FA Score: 1 green, 4 red.
  • VACBF’s FA Score: 1 green, 4 red.
According to our system of comparison, BPTSY is a better buy in the long-term than VACBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPTSY’s TA Score shows that 2 TA indicator(s) are bullish while VACBF’s TA Score has 1 bullish TA indicator(s).

  • BPTSY’s TA Score: 2 bullish, 4 bearish.
  • VACBF’s TA Score: 1 bullish, 1 bearish.
According to our system of comparison, VACBF is a better buy in the short-term than BPTSY.

Price Growth

BPTSY (@Biotechnology) experienced а -1.78% price change this week, while VACBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VACBF($93M) has a higher market cap than BPTSY($2.52M). VACBF (-84.759) and BPTSY (-88.669) have similar YTD gains . BPTSY has higher annual earnings (EBITDA): -15.13M vs. VACBF (-45.34M). VACBF has higher revenues than BPTSY: VACBF (6.15M) vs BPTSY (0).
BPTSYVACBFBPTSY / VACBF
Capitalization2.52M93M3%
EBITDA-15.13M-45.34M33%
Gain YTD-88.669-84.759105%
P/E RatioN/AN/A-
Revenue06.15M-
Total CashN/A137M-
Total DebtN/A4.79M-
TECHNICAL ANALYSIS
Technical Analysis
BPTSYVACBF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
20%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
6%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
25%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
19%
View a ticker or compare two or three
Ad is loading...
BPTSY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VACBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IDAI0.420.03
+8.95%
T Stamp
DX12.57-0.14
-1.10%
Dynex Capital
GEN29.38-0.35
-1.18%
Gen Digital
CFFI76.86-1.50
-1.91%
C&F Financial Corp
MCY70.56-2.30
-3.16%
Mercury General Corp

BPTSY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPTSY has been closely correlated with CDTX. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if BPTSY jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPTSY
1D Price
Change %
BPTSY100%
-16.71%
CDTX - BPTSY
92%
Closely correlated
-1.93%
PIRS - BPTSY
89%
Closely correlated
N/A
NGNE - BPTSY
38%
Loosely correlated
-5.61%
RNAZ - BPTSY
36%
Loosely correlated
-6.17%
VRCA - BPTSY
27%
Poorly correlated
-2.51%
More

VACBF and

Correlation & Price change

A.I.dvisor tells us that VACBF and EYEN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VACBF and EYEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VACBF
1D Price
Change %
VACBF100%
N/A
EYEN - VACBF
32%
Poorly correlated
+7.84%
SPHRY - VACBF
27%
Poorly correlated
+8.81%
RVPH - VACBF
22%
Poorly correlated
-39.13%
ZBIO - VACBF
21%
Poorly correlated
+8.10%
BPTSY - VACBF
20%
Poorly correlated
-16.71%
More